Financial statements Analgomed

Balance sheet of Analgomed

Company age:
Age:
8 y. 11 m. 23 d.
Share capital:
Share capital:
410 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of ANALGOMED

Year
2018
2019
2020
2021
2022
2023
Total assets 261 258,75 174 299,49 123 213,49 198 053,87 57 582,70 56 623,55
A. Fixed assets 119 100,00 142 978,92 108 528,23 74 077,54 39 626,85 9 076,16
B. Current assets 142 158,75 31 320,57 14 685,26 123 976,33 17 955,85 47 547,39
C. Share capital contributions (basic funds) 0,00 - - - - -
D. Own shares (stocks) 0,00 - - - - -
Total liabilities 261 258,75 174 299,49 123 213,49 198 053,87 57 582,70 56 623,55
A. Equity 94 522,39 -342 914,36 -872 594,16 69 062,46 -617 679,36 -778 776,64
B. Liabilities and provisions for liabilities 166 736,36 517 213,85 995 807,65 128 991,41 675 262,06 835 400,19
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.